Journal Articles

Reactive oxygen species treatment in the management of wounds

Share this article

Reactive oxygen species treatment in the management of wounds

Matthew Dryden
30 June 2017

Bacterial and fungal biofilms are a significant problem in many clinical settings particularly wounds and soft tissue lesions by virtue of their increased tolerance towards conventionally prescribed antimicrobials (Percival and Bowler, 2004; Davis et al, 2006; Dryden et al, 2017a).

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.